Advertisement

Clonal Hematopoiesis Associated with Adverse Outcomes Following Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma

Christopher J. Gibson, R. Coleman Lindsley, Vatche Tchekmedyian, Jiantao Shi, Brenton G. Mar, Siddhartha Jaiswal, Alysia Bosworth, Liton F. Francisco, Jianbo He, Elizabeth A. Morgan, Ann S. LaCasce, John Koreth, Vincent T. Ho, Jerome Ritz, Sarah Nikiforow, Joseph H. Antin, Robert J. Soiffer, Stephen J. Forman, Franziska Michor, Donna S. Neuberg, Smita Bhatia, Ravi Bhatia and Benjamin L. Ebert

Article Information

Citation 
vol. 128 no. 22 986

Print ISSN 
Online ISSN 
History 
  • Published online December 1, 2016.


Contributors 
  • Christopher J. Gibson [MD], 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
  • R. Coleman Lindsley [MD PhD], 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
  • Vatche Tchekmedyian [MD], 2Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
  • Jiantao Shi [PhD], 3Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA
  • Brenton G. Mar [MD PhD], 4Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
  • Siddhartha Jaiswal [MD PhD], 5Division of Hematology, Brigham and Women's Hospital, Boston, MA
  • Alysia Bosworth, 6Department of Population Sciences, City of Hope National Medical Center, Duarte, CA
  • Liton F. Francisco [BS], 7Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
  • Jianbo He [MD], 8Division of Hematology/Oncology, University of Alabama Birmingham, Birmingham, AL
  • Elizabeth A. Morgan [MD], 9Department of Pathology, Brigham and Women's Hospital, Boston, MA
  • Ann S. LaCasce [MD], 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
  • John Koreth [MD], 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
  • Vincent T. Ho [MD], 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
  • Jerome Ritz [MD], 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
  • Sarah Nikiforow [MD PhD], 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
  • Joseph H. Antin [MD], 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
  • Robert J. Soiffer [MD], 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
  • Stephen J. Forman [MD], 10Department of Hematology and HCT, City of Hope National Medical Center, Duarte, CA
  • Franziska Michor [PhD], 3Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA
  • Donna S. Neuberg [ScD], 3Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA
  • Smita Bhatia [MD MPH], 11University of Alabama at Birmingham, Birmingham, AL
  • Ravi Bhatia [MD], 12Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
  • Benjamin L. Ebert [MD PhD], 13Division of Hematology, Brigham and Women's Hospital, Boston, MA,

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output